Vaxxel
Pharmaceuticals - Villeurbanne, Auvergne-Rhône-Alpes, France
Vaxxel Employees
Vaxxel Details
Vaxxel develops novel and proprietary live-attenuated vaccines candidate against bronchiolitis and pneumonia and in particular against human Metnapneumovirus and against human Respiratory Virus. Vaxxel is a spin off fom Virpath, the virology and human pathology Laboratory of the University Claude Bernard in Lyon (UCBL), France, and has been founded by Dr. Manuel Rosa-Calatrava Co-Director of Virpath (Lyon), Pr. Guy Boivin of the University of Laval (Quebec), by Denis Cavert, President of Vaxxel.
Website:
http://www.vaxxel.fr
Employees:
9
HQ:
Location:
Villeurbanne, Auvergne-Rhône-Alpes, France
Revenue:
1M
Vaxxel Technologies
Captcha
reCAPTCHA
Email Providers
Outlook
Load Balancers
Apache
CMS
WordPress.org
Fonts
Google Font API
Other
Mobile Friendly